文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Life Begins With Cells (细胞-生命的起源)-p601-700
侵权投诉

Life Begins With Cells (细胞-生命的起源)-p601-700

Life begins with cells. 很好的关于细胞是生命基础的生物化学的教材

menopausal women, resorption increases and the bonesweaken. It may be possible to develop new treatments for os-teoporosis based on altering the signaling system that con-trols bone resorption.

Life Begins With Cells (细胞-生命的起源)-p601-700

brane such that the C-terminal signal-transducing domainextends into the cytosol and the N-terminal ligand-bindingdomain extends into the extracellular space. With recombi-nant DNA techniques a stop codon can be placed in thecDNA encoding such a receptor so that translation in an ap-propriate expression system generates a truncated proteincorresponding to the receptor’s extracellular domain, whichwill be secreted and can function as a decoy receptor. For ex-ample, local increases in TNF- are frequent in rheumatoidarthritis,an inflammatory joint disease. Injection of the recombinant-produced extracellular domain of the TNF- receptor, which “soaks up” some of the excess TNF- andreduces inflammation, is now one of the major therapies forsevere cases of this disease.

KEY CONCEPTS OF SECTION 14.7Down-Modulation of Receptor Signaling

■

Endocytosis of receptor-hormone complexes and theirdegradation in lysosomes is a principal way of reducingthe number of receptor tyrosine kinases and cytokine re-ceptors on the cell surface, thus decreasing the sensitivityof cells to many peptide hormones.

■

Bone resorption is triggered by binding of RANKL onosteoblasts to its receptor, RANK, on osteoclasts.RANKL/RANK signaling promotes tight adhesion of os-teoclasts to bone and secretion of a bone-dissolving mix-ture of HCl and proteases by osteoclasts (see Figure 14-31).

■

Osteoprotegerin, a decoy receptor for RANKL, inhibitsosteoclast activation and bone resorption.

■

The extracellular domains of many cell-surface receptorscan be produced by recombinant DNA techniques and havepotential as therapeutic decoy receptors. Already in use issuch a decoy receptor for TNF- , which binds excess TNF- matory diseases.

associated with rheumatoid arthritis and other inflam-PERSPECTIVES FOR THE FUTURE

The confluence of genetics, biochemistry, and structural biol-ogy has given us an increasingly detailed view of how signalsare transmitted from the cell surface and transduced into

Perspectives for the Future

607

changes in cellular behavior. The multitude of different extra-cellular signals, receptors for them, and intracellular signal-transduction pathways fall into a relatively small number of classes, and one major goal is to understand how similar signaling pathways often regulate very different cellularprocesses. For instance, STAT5 activates very different sets ofgenes in erythroid precursor cells, following stimulation of the erythropoietin receptor, than in mammary epithelial cells,following stimulation of the prolactin receptor. PresumablySTAT5 binds to different groups of transcription factors inthese and other cell types, but the nature of these proteins andhow they collaborate to induce cell-specific patterns of geneexpression remain to be uncovered.

Conversely, activation of the same signal-transductioncomponent in the same cell through different receptors oftenelicits different cellular responses. One commonly held viewis that the duration of activation of the MAP kinase andother signaling pathways affects the pattern of gene expres-sion. But how this specificity is determined remains an out-standing question in signal transduction. Genetic andmolecular studies in flies, worms, and mice will contribute toour understanding of the interplay between different path-way components and the underlying regulatory principlescontrolling specificity in multicellular organisms.

Researchers have determined the three-dimensional struc-tures of various signaling proteins during the past severalyears, permitting more detailed analysis of several signal-transduction pathways. The molecular structures of differentkinases, for example, exhibit striking similarities and impor-tant variations that impart to them novel regulatory features.The activity of several kinases, such as Raf and protein kinaseB (PKB), is controlled by inhibitory domains as well as by mul-tiple phosphorylations catalyzed by several other kinases. Butour understanding of how the activity of these and other ki-nases is precisely regulated to meet the cell’s needs will requireadditional structural and cell biological studies.

Abnormalities in signal transduction underlie many dif-ferent diseases, including the majority of cancers and manyinflammatory conditions. Detailed knowledge of the signal-ing pathways involved and the structure of their constituentproteins will continue to provide important molecular cluesfor the design of specific therapies. Despite the close struc-tural relationship between different signaling molecules (e.g.,kinases), recent studies suggest that inhibitors selective for specific subclasses can be designed. In many tumors of epithelial origin, the EGF receptor exhibits constitutive(signal-independent) protein tyrosine kinase activity, and aspecific inhibitor of this kinase (Iressa ) has proved usefulin the treatment of several such cancers. Similarly, mono-clonal antibodies or decoy receptors that prevent pro-inflammatory cytokines like IL-1 and TNF- from binding totheir cognate receptors are now being used in treatment ofseveral inflammatory diseases such as arthritis.

Drugs that target other signal-transducing proteins maybe useful in controlling their abnormal activities. One exam-ple is Ras, which is anchored to cell membranes by farnesyl

上一页第4页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email